SAM
Simplify Asset Management Portfolio holdings
AUM
$1.65B
This Quarter Return
-1.3%
1 Year Return
+8.73%
3 Year Return
+37.73%
5 Year Return
–
10 Year Return
–
AUM
$607M
AUM Growth
+$607M
(+10%)
Cap. Flow
+$75.3M
Cap. Flow
% of AUM
12.42%
Top 10 Holdings %
Top 10 Hldgs %
73.88%
Holding
132
New
13
Increased
28
Reduced
42
Closed
13
Top Buys
| 1 |
Simplify Aggregate Bond ETF
AGGH
|
$50.8M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$35.8M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
$5.57M |
| 4 |
Plains GP Holdings
PAGP
|
$5.28M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$4.43M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$23.2M |
| 2 |
Plains All American Pipeline
PAA
|
$9.17M |
| 3 |
Simplify High Yield ETF
CDX
|
$3.81M |
| 4 |
Simplify Stable Income ETF
BUCK
|
$2.81M |
| 5 |
Simplify Volatility Premium ETF
SVOL
|
$2.74M |
Sector Composition
| 1 | Healthcare | 15.33% |
| 2 | Energy | 3.65% |
| 3 | Financials | 0.86% |
| 4 | Technology | 0.84% |
| 5 | Industrials | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
iShares Gold Trust
IAU
$50.6B
| $1.9M | 0.22% |
54,228
-26,651
| -33% | -$933K |
|
52
Simplify Intermediate Term Treasury Futures Strategy ETF
TYA
$90.2M
| $1.74M | 0.2% |
137,116
-67,396
| -33% | -$857K |
|
53
Zimmer Biomet
ZBH
$21B
| $1.7M | 0.19% |
15,179
-4,309
| -22% | -$484K |
|
|
EQLS
54
DELISTED
Simplify Market Neutral Equity Long/Short ETF
EQLS
| $1.66M | 0.19% |
67,056
-32,944
| -33% | -$817K |
|
55
PureCycle Technologies
PCT
$2.57B
| $1.59M | 0.18% |
283,945
+140,455
| +98% | +$788K |
|
56
argenx
ARGX
$43.6B
| $1.49M | 0.17% |
3,038
-35
| -1% | -$17.2K |
|
57
Becton Dickinson
BDX
$55.3B
| $1.47M | 0.17% |
5,695
-65
| -1% | -$16.8K |
|
|
EMD
58
Western Asset Emerging Markets Debt Fund
EMD
$599M
| $1.37M | 0.16% |
+165,500
| New | +$1.37M |
|
59
Gilead Sciences
GILD
$140B
| $1.35M | 0.15% |
17,974
+6,764
| +60% | +$507K |
|
60
Seres Therapeutics
MCRB
$166M
| $1.31M | 0.15% |
550,626
| – | – |
|
61
AGF US Market Neutral Anti-Beta Fund
BTAL
$385M
| $1.28M | 0.15% |
+64,592
| New | +$1.28M |
|
62
Saratoga Investment
SAR
$407M
| $1.25M | 0.14% |
+48,500
| New | +$1.25M |
|
63
Kayne Anderson Energy Infrastructure Fund
KYN
$2.12B
| $1.24M | 0.14% |
147,033
| – | – |
|
64
Stryker
SYK
$150B
| $1.21M | 0.14% |
4,434
-50
| -1% | -$13.7K |
|
|
MRNS
65
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.21M | 0.14% |
150,000
| – | – |
|
66
Annexon
ANNX
$226M
| $1.16M | 0.13% |
492,595
-160,888
| -25% | -$380K |
|
67
Humana
HUM
$36.5B
| $873K | 0.1% |
1,795
+1,169
| +187% | +$569K |
|
68
Thermo Fisher Scientific
TMO
$186B
| $868K | 0.1% |
1,715
-1,543
| -47% | -$781K |
|
|
EIGR
69
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $824K | 0.09% |
2,700,000
+1,600,347
| +146% | +$488K |
|
70
Avidity Biosciences
RNA
$5.99B
| $798K | 0.09% |
125,000
| – | – |
|
71
Allogene Therapeutics
ALLO
$251M
| $777K | 0.09% |
245,000
| – | – |
|
72
Kura Oncology
KURA
$686M
| $730K | 0.08% |
80,000
| – | – |
|
73
Exact Sciences
EXAS
$8.98B
| $657K | 0.08% |
9,635
-12,498
| -56% | -$853K |
|
74
Quanterix
QTRX
$211M
| $644K | 0.07% |
+23,718
| New | +$644K |
|
75
Establishment Labs
ESTA
$1.2B
| $625K | 0.07% |
12,733
-145
| -1% | -$7.12K |
|